Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions (FSS-QLS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01307475 |
Recruitment Status :
Terminated
(Most study procedures incorporated into NCT01144741, some in NCT01306994)
First Posted : March 3, 2011
Last Update Posted : April 4, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Freeman-Sheldon syndrome (FSS) is a rare human neuromusculoskeletal disorder present before birth, involving primarily limb and craniofacial deformities.
The hypotheses in the present study of FSS and related conditions are: (1) FSS and related conditions are associated with higher rates of posttraumatic stress symptoms (PTSS), depression, and reduced quality of life than is observed in the general population; (2) persons close to an individual with FSS or related condition suffer similarly; and (3) current measures, which are single-disease specific (i.e., PTSS, depression, craniofacial deformities, or limb deformities), do not capture the unique picture of FSS and related conditions, which involve both limb and craniofacial deformities in an intellectually capable individual.
There have been no studies looking at quality of life associated with FSS. Some authors have looked at quality of life in persons with facial differences; other authors have looked at bone and joint problems. Many other authors have looked at PTSS and depression caused by health problems and bad medical experiences. No authors have looked at these problems when they happen together, as they do in FSS. Because of the above, there may be differences in patients that have FSS versus patients in previous quality of life studies. The study will also develop and validate an outcomes-based quality of life survey for FSS and related conditions.
Condition or disease | Intervention/treatment |
---|---|
Arthrogryposis Craniofacial Abnormalities Posttraumatic Stress Disorder Depressive Disorder | Other: PTSD Checklist-Specific Other: Modified Flanagan Quality of Life Scale Other: Center for Epidemiologic Studies Depression Scale Other: Functional Enquiry Form Other: Strength, Joint ROM, Girth and Length Measurements Other: Study Physical Examination Other: PTSD, Depression, and FSS-Focused Examination Other: Freeman-Sheldon Specific Quality of Life Survey Other: Lactate, Glucose, and Adenosine Triphosphate Blood Levels |
This study is a research project initiated by the graduate research student (Mikaela I. Poling) and assisted by the clinical genetics fellow and graduate student (Andrés Morales) in partial fulfilment the requirements for their Masters degrees in Clinical and Applied Physiology, under approval, direction, and supervision of the study PI (Rodger J. McCormick).
Mental Health and Congenital Deformities:
Apajasalo et al. (1998) found significantly decreased health-related quality of life versus controls among adults and youth ages with chondrodysplasias. Differences in adult scores were in the areas of mobility, usual activities, and sexual activity and discomfort. Youth scores differed more in school and hobbies and friends and physical appearance. Didierjean-Pillet (2002) stressed concern for aesthetics of reconstruction in consideration of psychiatric impacts of congenital deformities in psychosocial functioning. Nagata et al. (2008) found that 20% of mothers with children operated on for congenital disease were likely to have post-traumatic stress disorder (PTSD). They found that pro-active, effective participation in the child's care may alleviate PTSS. Vitale et al. (2005) found quality of life survey scores among clubfoot patients compatible with age-matched controls, in agreement with Roye (2001), and not correlated to radiograph appearance. They advised quality of life survey scores be primary endpoint in determining therapeutic outcome. Engell et al. (2007) found significant post-operative improvement in the Short Form-12 Health Survey physical component scale in congenital clubbed-foot patients in the Danish Twin Registry. Vitale et al. (2001) observed that tailored quality of life scales were required for paediatric orthopaedic populations. Hawkins and Radcliffe (2006) concluded there was a lack of appropriate and validated PTSD measures for paediatric patients. Part of this problem of lacking validated paediatric PTSD measures was likely do to non-comprehensive Diagnostic and Statistical Manual of Mental Disorders IV Text-Revision criteria.
Relevance to Current Study:
Because FSS-related deformities were more comprehensive, treatment-resistant, and associated with poorer clinical outcome, quality of life studies not including a subset of FSS patients may not be appropriate in the more challenging clinical picture of FSS-related deformities. In many conditions, disorder-specific quality of life measures (QLM) showed increased sensitivity and specificity over general QLMs and were important therapeutic tools to assess efficacy of and prioritise interventions. Results of disorder-specific QLMs were important predictors of clinical outcome.
Study Type : | Observational |
Actual Enrollment : | 6 participants |
Observational Model: | Case-Only |
Time Perspective: | Cross-Sectional |
Official Title: | Freeman-Sheldon Syndrome Quality of Life Study (FSS-QLS): Cross-sectional Study of Concomitant Disorder-Specific Contributors to Quality of Life and Clinical Outcome |
Study Start Date : | February 2011 |
Actual Primary Completion Date : | April 1, 2017 |
Actual Study Completion Date : | April 1, 2017 |

Group/Cohort | Intervention/treatment |
---|---|
Proband Group
Patients identified with FSS or a related condition
|
Other: PTSD Checklist-Specific
Completed by patients before clinical examination; it is a 17-item survey listing of symptoms of posttraumatic stress disorder.
Other Names:
Other: Modified Flanagan Quality of Life Scale Completed by patients before clinical examination; it is a 16-item survey designed for use in persons with chronic illness.
Other Names:
Other: Center for Epidemiologic Studies Depression Scale Completed by patients before clinical examination; it is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Other Name: CES-D Other: Functional Enquiry Form Completed by patients before clinical examination; it is a checklist of medical problems.
Other Names:
Other: Strength, Joint ROM, Girth and Length Measurements Completed during the clinical examination by the researchers, it is a structured approach to evaluation of muscles, joints, arms, thighs, and legs.
Other Names:
Other: Study Physical Examination Completed during the clinical examination by the researchers, it is a structured approach to a full physical examination, minus breasts, genitalia or rectum.
Other Names:
Other: PTSD, Depression, and FSS-Focused Examination Completed during the clinical examination by the researchers, it is a structured approach to evaluation of symptoms, signs, and perceptions that may be related to FSS, PTSS, or depressive problems.
Other Names:
Other: Freeman-Sheldon Specific Quality of Life Survey Completed after data analysis from the existing surveys and clinical examination, it will be a specific quality of life survey developed and tested during the study; it will take into consideration individual's total health outcome.
Other Names:
Other: Lactate, Glucose, and Adenosine Triphosphate Blood Levels Completed during the clinical examination by the researchers, lactate, glucose, and free and total adenosine triphosphate blood levels are determined at rest.
Other Names:
|
Family Group
Persons who are genetically or legally related to a person with FSS or related condition
|
Other: PTSD Checklist-Specific
Completed by patients before clinical examination; it is a 17-item survey listing of symptoms of posttraumatic stress disorder.
Other Names:
Other: Modified Flanagan Quality of Life Scale Completed by patients before clinical examination; it is a 16-item survey designed for use in persons with chronic illness.
Other Names:
Other: Center for Epidemiologic Studies Depression Scale Completed by patients before clinical examination; it is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Other Name: CES-D Other: Functional Enquiry Form Completed by patients before clinical examination; it is a checklist of medical problems.
Other Names:
Other: Strength, Joint ROM, Girth and Length Measurements Completed during the clinical examination by the researchers, it is a structured approach to evaluation of muscles, joints, arms, thighs, and legs.
Other Names:
Other: Study Physical Examination Completed during the clinical examination by the researchers, it is a structured approach to a full physical examination, minus breasts, genitalia or rectum.
Other Names:
Other: PTSD, Depression, and FSS-Focused Examination Completed during the clinical examination by the researchers, it is a structured approach to evaluation of symptoms, signs, and perceptions that may be related to FSS, PTSS, or depressive problems.
Other Names:
Other: Freeman-Sheldon Specific Quality of Life Survey Completed after data analysis from the existing surveys and clinical examination, it will be a specific quality of life survey developed and tested during the study; it will take into consideration individual's total health outcome.
Other Names:
Other: Lactate, Glucose, and Adenosine Triphosphate Blood Levels Completed during the clinical examination by the researchers, lactate, glucose, and free and total adenosine triphosphate blood levels are determined at rest.
Other Names:
|
Other Affected Individuals Group
Persons who have had significant and meaningful contact with a person with FSS or related condition but do not qualify for family group enrolment
|
Other: PTSD Checklist-Specific
Completed by patients before clinical examination; it is a 17-item survey listing of symptoms of posttraumatic stress disorder.
Other Names:
Other: Modified Flanagan Quality of Life Scale Completed by patients before clinical examination; it is a 16-item survey designed for use in persons with chronic illness.
Other Names:
Other: Center for Epidemiologic Studies Depression Scale Completed by patients before clinical examination; it is a 20-item survey that asks about depressive feelings and behaviours in the past week.
Other Name: CES-D Other: Functional Enquiry Form Completed by patients before clinical examination; it is a checklist of medical problems.
Other Names:
Other: Strength, Joint ROM, Girth and Length Measurements Completed during the clinical examination by the researchers, it is a structured approach to evaluation of muscles, joints, arms, thighs, and legs.
Other Names:
Other: Study Physical Examination Completed during the clinical examination by the researchers, it is a structured approach to a full physical examination, minus breasts, genitalia or rectum.
Other Names:
Other: PTSD, Depression, and FSS-Focused Examination Completed during the clinical examination by the researchers, it is a structured approach to evaluation of symptoms, signs, and perceptions that may be related to FSS, PTSS, or depressive problems.
Other Names:
Other: Freeman-Sheldon Specific Quality of Life Survey Completed after data analysis from the existing surveys and clinical examination, it will be a specific quality of life survey developed and tested during the study; it will take into consideration individual's total health outcome.
Other Names:
Other: Lactate, Glucose, and Adenosine Triphosphate Blood Levels Completed during the clinical examination by the researchers, lactate, glucose, and free and total adenosine triphosphate blood levels are determined at rest.
Other Names:
|
- Situational Mental Health in Persons with FSS or Related Condition [ Time Frame: Evaluated during 1-2 study visits (lasting an average of 1-3 hours each) and in self-completed surveys, over an average of 2-4 years from enrolment ]Increased frequency of mental health symptoms and diagnoses (PTSS, Depression, and reduced quality of life) over expected for general population
- Situational Mental Health in Family and Others with a Close Relationship to a Person with FSS or Related Condition [ Time Frame: Evaluated during 1-2 study visits (lasting an average of 1-3 hours each) and in self-completed surveys, over an average of 2-4 years from enrolment ]Increased frequency of mental health symptoms and diagnoses (PTSS, Depression, and reduced quality of life) over expected for general population
- Current Survey Correlation with Disorder-Specific Survey for FSS and Related Conditions [ Time Frame: Evaluated during 1-2 study visits (lasting an average of 1-3 hours each) and in self-completed surveys, over an average of 2-4 years from enrolment ]Ability of current surveys to capture full picture of quality of life for persons, families, and others affected by FSS and related conditions will be assessed to determine need for a disorder-specific survey and usefulness of existing surveys.
Biospecimen Retention: None Retained

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Freeman-Sheldon syndrome,
- Sheldon-Hall syndrome,
- Distal arthrogryposis type 1, or
- distal arthrogryposis type 3
- Deceased probands with enough clinical information available to satisfy study requirements
- Probands who participated in a prior Freeman-Sheldon Research Group (FSRG)-study are automatically accepted, since their diagnoses have been confirmed by FSRG clinical faculty.
- Probands with a reported qualifying diagnosis, who have not participated in a prior FSRG-study, will be required to complete the complete a survey from a prior study and provide photographs and any requested medical records to confirm their diagnoses.
- Family members and other close contacts may enrol, so long as they have either resided with or had substantial and prolonged contact with a proband, who has an FSRG-verified qualifying diagnosis. Investigators will make the final decision on a case-by-case basis, based on information provided.
Exclusion Criteria:
- Patients with other anomalies, not having one of the above syndromes, will not be accepted.
- Deceased probands will not be accepted for analysis, without enough clinical data available to satisfy study data collection requirements.
- Patients or parents of minor children not willing to give consent will not be included.
- Family members or other contacts that neither resided with nor had substantial and prolonged contact with the proband.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01307475
United States, West Virginia | |
Freeman-Sheldon Research Group, Inc. Headquarters | |
Buckhannon, West Virginia, United States, 26201 | |
Guatemala | |
San Juan de Dios General Hospital | |
Guatemala City, Guatemala |
Principal Investigator: | Robert L Chamberlain, MD | Freeman-Sheldon Research Group, Inc. |
Publications of Results:
Other Publications:
Responsible Party: | Freeman-Sheldon Research Group, Inc. |
ClinicalTrials.gov Identifier: | NCT01307475 |
Other Study ID Numbers: |
000082 U1111-1120-5996 ( Other Identifier: World Health Organisation, Universal Trial Number ) |
First Posted: | March 3, 2011 Key Record Dates |
Last Update Posted: | April 4, 2017 |
Last Verified: | April 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Individual patient data will not be shared, due to concerns involved in masking identities of individuals with such a rare condition. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Chronic Post-Traumatic Stress Disorder Delayed Onset Post-Traumatic Stress Disorder Post-Traumatic Neuroses Posttraumatic Neuroses Post-Traumatic Stress Disorders Posttraumatic Stress Disorders PTSD Post TraumaticStress Disorder Endogenous Depression |
Neurotic Depression Depressive Syndrome Melancholia Depressive Neurosis Unipolar Depression Depressive Symptoms Emotional Depression Quality of Life |
Arthrogryposis Craniofacial Abnormalities Disease Depressive Disorder Stress Disorders, Traumatic Stress Disorders, Post-Traumatic Pathologic Processes Mood Disorders Mental Disorders Trauma and Stressor Related Disorders Congenital Abnormalities Joint Diseases Musculoskeletal Diseases Muscular Diseases |
Musculoskeletal Abnormalities Adenosine Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Arrhythmia Agents Vasodilator Agents Purinergic P1 Receptor Agonists Purinergic Agonists Purinergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |